BBIO News
Archived Headlines
- June's flood of biotech IPOs continues with these 4 deals 06/24/19
- US IPO Week Ahead: Tech and big biotech fill up a 9-IPO week 06/21/19
- KKR IPO BridgeBio 06/21/19
- June is getting a flood of biotech IPOs with these 9 deals on the calendar 06/18/19
- KKR-backed genetic disease biotech BridgeBio sets terms for $225 million IPO 06/17/19
See more
US IPO Week Ahead: The IPO market takes its holiday vacation
There are no companies scheduled for the holiday week ahead, and we likely won’t see any more IPOs until 2020. Lock-up periods will be expiring for seven companies. On Monday, December 23: Cambium Networks (CMBM). On Tuesday,...read more
US IPO Weekly Recap: Big biotechs score big as Adaptive soars 142%
Eight companies raised $2.1 billion this past week, capping off the US IPO market's largest quarter in five years. The week was split between tech and biotechs, including two in the biotech space that went public at valuations of more than $2.0 billion. Over 10...read more
BridgeBio Pharma prices upsized IPO above the range at $17 in year's largest biotech IPO
BridgeBio Pharma, a late-stage biotech developing therapies for genetic diseases and cancers, raised $349 million by offering 20.5 million shares at $17, above the range of $14 to $16. The company previously filed to offer 20.0 million shares, after first...read more
KKR-backed genetic disease platform BridgeBio Pharma increases proposed share offering by 33%
BridgeBio Pharma, a late-stage biotech developing therapies for genetic diseases and cancers, raised the proposed deal size for its upcoming IPO on Wednesday. The Palo Alto, CA-based company now plans to raise $300 million by offering 20 million shares, up...read more